Reduced expression levels of the death-associated protein kinase and E-cadherin are correlated with the development of esophageal squamous cell carcinoma

Experimental and Therapeutic Medicine

Volumn 5, Issue 3, 2013, Pages 972-976

  Zhai, Jianwen ^a   Yang, Xiaogang ^a   Zhang, Yanli ^a   Qi, Qingbin ^a   Hu, Jigang ^a   Wang, Qiaomei ^a  

^a HEBEI UNIVERSITY OF ENGINEERING   (China)

Author keywords

Death associated protein kinase; E cadherin; Esophageal squamous cell carcinoma

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84873164336     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.916     Document Type: Article

References (14)

1. Deiss LP, Feinstein E, Berissi H, Cohen O and KimchiA: Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators ofthe gamma interferon-induced cell death. Genes Dev 9: 15-30, 1995.
2. Brabender J, Arbab D, Huan X, et al: Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Ann Surg Oncol 16: 1378-1383, 2009.
3. Tong A, Lynn G, Ngo V, et al: Negative regulation of Caenorhabditis elegans epidermal damage responses by death-associated protein kinase. Proc Natl Acad Sci USA 106: 1457-1461, 2009.
4. Li H, Ray G, Yoo BH, Erdogan M and Rosen KV: Down-regulation of death-associated protein kinase-2 is required for beta-catenin-induced anoikis resistance of malignant epithelial cells. Biol Chem 284: 2012-2022, 2009.
5. Zalckvar E, Berissi H, Eisenstein M and Kimchi A: Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy 5: 720-722, 2009.
6. Yanagawa N, Osakabe M, Hayashi M, Tamura G and MotoyamaT: Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int 58: 477-482, 2008.
7. Hoffmann AC, Vallböhmer D, Prenzel K, et al: Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. JCancer Res Clin Oncol 135: 1231-1237, 2009.
8. Fendri A, Masmoudi A, Khabir A, et al: Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Cancer Biol Ther 8: 444-451, 2009.
9. Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, et al: E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 11: E100-E105, 2006.
10. Zhai JW, Yang XG, Yang FS, Hu JG and Hua WX: Expression and clinical significance of Ezrin and E-cadherin in esophageal squamous cell carcinoma. Chin J Cancer 29: 317-320, 2010.
11. Gao DL, Li SL, Chen KS, Zhao ZH, Zhao QM, Liu ZW and ZhangYH: The inhibition of metalloproteinase in RECK expression in esophageal squamous cell carcinoma and its biological significance. World J Gastroenterol 16: 1634-1638, 2008.
12. Gonzalez MA, Pinder SE, Wencyk PM, et al: An immunohistochemical examination of the expression of E-cadherin, alpha-and beta/gamma-catenins, and alpha2-and betal-integrins in invasive breast cancer. J Pathol 187: 523-529, 1999.
13. Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL and Du Z: Aberrant methylation of multiple genes and its clinical implication in hepatocellularcarcinoma. Zhonghua Zhong Liu Za Zhi 30: 831-836, 2008 (In Chinese).
14. Bajbouj K, Poehlmann A, Kuester D, et al: Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFalpha-induced apoptosis in colorectal tumor cells. Am J Pathol 175: 557-570, 2009.